These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10309316)

  • 1. 'Hit list' of infection control measures compiled.
    McGowan JE
    Infect Control Dig; 1981 Jan; 2(1):1-2. PubMed ID: 10309316
    [No Abstract]   [Full Text] [Related]  

  • 2. Hospital infection control survival depends on cost and benefit analysis.
    Infect Control Dig; 1982 Jul; 3(7):1-2. PubMed ID: 10309667
    [No Abstract]   [Full Text] [Related]  

  • 3. ICPs must analyze costs, benefits of IC measures.
    McGowan J
    Hosp Infect Control; 1982 Aug; 9(8):101-3. PubMed ID: 10309777
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and control of viral hospital infections.
    Agut H
    Am J Infect Control; 2001 Aug; 29(4):244-6. PubMed ID: 11486264
    [No Abstract]   [Full Text] [Related]  

  • 5. Infection-control strategies save $250,000 annually.
    Haley R
    Hospitals; 1985 Nov; 59(22):63-5. PubMed ID: 3932183
    [No Abstract]   [Full Text] [Related]  

  • 6. Survey of infection control infrastructure in selected southern and eastern Mediterranean hospitals.
    Borg MA; Cookson BD; Scicluna E;
    Clin Microbiol Infect; 2007 Mar; 13(3):344-6. PubMed ID: 17391397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Internal quality management, institutional guidelines and "infection control". A comprehensive concept of control in hospitals].
    Schrappe M
    Dtsch Med Wochenschr; 2002 Feb; 127(5):217-21. PubMed ID: 11821997
    [No Abstract]   [Full Text] [Related]  

  • 8. [A survey on nosocomial tuberculosis infection control in hospitals in Osaka City].
    Shimouchi A; Konishi S; Tanaka T
    Kekkaku; 2005 Dec; 80(12):743-7. PubMed ID: 16447787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection control: practitioners should emphasize financial aspects of programs.
    Phillips D
    Hospitals; 1982 Jul; 56(14):66. PubMed ID: 6806169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of medium-sized independent laboratories in control of healthcare-associated infection].
    Anzai E; Fukui T
    Rinsho Byori; 2009 May; 57(5):467-70. PubMed ID: 19522254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit and effectiveness of nosocomial surveillance methods.
    Obasanjo O; Perl TM
    Curr Clin Top Infect Dis; 2001; 21():391-406. PubMed ID: 11572161
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory provides crucial infection control services.
    McGowan J
    Hosp Infect Control; 1983 May; 10(5):57-9. PubMed ID: 10309990
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective decontamination of the digestive tract.
    Silvestri L; Mannucci F; van Saene HK
    J Hosp Infect; 2001 Aug; 48(4):322-4. PubMed ID: 11461137
    [No Abstract]   [Full Text] [Related]  

  • 14. Infection control could save millions.
    Graham J
    Mod Healthc; 1985 Jan; 15(1):104. PubMed ID: 10270796
    [No Abstract]   [Full Text] [Related]  

  • 15. How to design a cost-effective infection control program.
    Cost Containment; 1985 Aug; 7(15):3-6. PubMed ID: 10314136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of supportive therapy in cancer patients.
    Wolf MM
    Aust Health Rev; 1982 May; 5(2):29-31. PubMed ID: 10309736
    [No Abstract]   [Full Text] [Related]  

  • 17. [Silver coated urinary catheters. Clinical effectiveness and cost-benefit analysis].
    Panknin HT
    Med Monatsschr Pharm; 2005 Oct; 28(10):368-70. PubMed ID: 16245460
    [No Abstract]   [Full Text] [Related]  

  • 18. Filters may add cost without protection.
    Same Day Surg; 1979 Sep; 3(9):107-9. PubMed ID: 10309064
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective decontamination of the digestive tract, SDD: a commentary.
    Webb CH
    J Hosp Infect; 2000 Oct; 46(2):106-9. PubMed ID: 11049702
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current communicable disease control--part 2. What does it cost and who is to pay?].
    Källenius G; Andersson D
    Lakartidningen; 2000 Oct; 97(42):4732-6. PubMed ID: 11079324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.